Aniracetam
Status |
Commercial |
Therapeutic cat. |
Neurology |
Polymorphic form |
Monoclinic form |
CAS No. |
72432-10-1 |
EU DMF readiness |
 |
Drug description
Aniracetam is a cognitive enhancer employed to improve memory and attention issues associated with cerebrovascular conditions and degenerative brain diseases.
Disclaimer: Products protected by patents (SPC) in Poland are developed solely for the purpose of Regulatory Submissions or R&D purposes intended to support Regulatory Submissions. These products are not offered for sale or made available in countries where such products are subject to patent (SPC) protection and where the offer for sale or any related activity constitutes patent infringement. It is within the buyer’s responsibility and liability to check the patent situation of the product in the import market(s). |